– iECURE (pronounced EE-ah-cure), a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet need, announced it has closed a $50m Series A financing led by Versant Ventures and OrbiMed Advisors.
– The funds will be used to advance iECURE’s pipeline of up to 13 programs, all of which benefit from gene editing and in vivo delivery approaches being developed in the laboratory of James Wilson, M.D., Ph.D., of the University of Pennsylvania Gene Therapy Program (GTP).
– iECURE’s approach focuses on the mutation-agnostic in vivo insertion of healthy copies of disease-causing genes, with an initial focus in liver disorders.

– Revery, a sleep-focused mobile app, raised $2m in funding.
– The round was led by Sequoia Capital India‘s Surge program and joined by GGV Capital, Pascal Capital, zVentures (Razer’s corporate venture arm) and angel investors like MyFitnessPal co-founder Albert Lee; gaming entrepreneur Juha Paananen; CRED founder Kunal Shah; Mobile Premier League founder Sai Srinivas; Carolin Krenzer; and Josh Lee.
– The company plans to launch its app in the United States later this year.

– 87%, a London, UK-based workplace wellbeing platform provider, raised £1.6M in seed funding.
– The round was led by Aviva Foundation.
– The company intends to use the funds to continue to expand its business reach into the corporate sector.

– Heru Inc. closed its Series A financing of $30m to advance the company’s eye diagnostic and vision correction technology platform.
– The Series A funding round was led by global investment firm D1 Capital Partners with participation from SoftBank Ventures Opportunity Fund, Maurice R. Ferre, M.D., Frederic H. Moll, M.D., Krillion Ventures, and a consortium of investors with extensive experience developing, launching and scaling cutting-edge medical technologies.
– Originating as a spinout from Bascom Palmer Eye Institute, the Series A follows FDA registration and a $2.7m seed round announced in December 2020.
– An estimated 450m people worldwide experience visual field defects or double vision, but limited access can mean long waits for eye appointments.

– LIT Method, the fitness company specializing in high-intensity, Low Impact Training (LIT™), and its founders, Justin and Taylor Norris, today announced an investment from Marcy Venture Partners (MVP).
– The round also includes an investment from former Los Angeles Dodger and five-time MLB All-Star Adrian Gonzalez.
– Through its Los Angeles-based fitness studio, LIT On-Demand platform, and patent pending multifunctional LIT Strength Machine, LIT Method delivers a first of its kind, high-intensity, low impact strength training workout.

– Redcon1 closes strategic investment from Trivest Partners.
– The amount of the deal was not disclosed.
– The company intends to use the capital to extend it product breadth and distribution reach worldwide.
– Led by Aaron Singerman, Founder, and Eric Hart, President and co-owner, Redcon1 is a sports nutrition brand that offers a diversified set of products to over 80 countries worldwide.

– Recuro Health from Dallas is a digital health solution provider.
– The company raised an undisclosed amount of funding in a funding round led by OLSF Ventures with participation from Cortado Ventures, 1843 Capital and Sage Venture Partners.
– The new investment will be used to expand operations and development efforts.

– Better Health, a San Francisco, CA-based medical supplier offering an e-commerce experience and service to Americans with chronic conditions, raised $3.5m in seed funding.
– The round was led by 8VC with participation from Caffeinated Capital and Anorak Ventures, Robert Hurley and Scott Flanders of eHealth.
– The new investment will be used to accelerate growth and expand the company’s product offerings.